ࡱ>   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnwpqrstuv{xyz|Root Entry F@dSummaryInformation(,DocumentSummaryInformation8 WordDocument3  Oh+'0   ( 4 @ LX`hplenovo Normal.dotm\H8@yO@\Np@@f.w )=WPS Office_12.1.0.16929_F1E327BC-269C-435d-A152-05C5408002CA ՜.+,D՜.+,HPXpx ^Nw;Sf[O\- 0t|KSOProductBuildVerICV2052-12.1.0.16929$7DF134A4411F4A9A8CF51D4297BB8857_13,0TableoData WpsCustomData0 PdKSKS3L.++b L | $n h4 : vCV@ h lQ:yQ[ cPVYy ;Sf[yb/gVY NI{VY yv Ty _RpzvY~^NN\O(uxvzS^(u cPUSMO /n'Yf[m3W;Sb cPa Y/TR`Yec/f/n'Yf[m3W;Sb_@{~TQyv;N{ яt^egYYec(W_@{W!.szQ (Wc:y2W|?\uր[_p`_~gTRvq_T0'`+R]_q_T_SۏU\!j_0@Fmˆ}vN][͑gT _RvvsQ'`I{ebcQev‰p bU\N_Rpzv4N^xvzt0яNt^ ShSCIeǏ40{0yOv;Sub yv3uNN_RpzvY|~NNW@x:g6Rxvz 0R_RpzN$v0|?\uNNq_Tv4N^'Ypencc"} V[:y~_RpzS_^ Y-N_vR^[e Ng㉳QS_MR_pWb4Nv:g6Rxvz04N^c"}TeHh[evN|R :N_pWv;Sf[SU\cORR0 2 яt^]\ObgT TLċ 3uNVяt^eg;NǏ4N^'Ypencxvz c_~gRNQRl|~uuvsQT'`0c"}_ʋub/gvORNSSsN@l{|oir[_Rpzvq_T wQSOY N `$N@l{|oir\O(uveSs3uNV!kSs O(uN@l{|oirN_Rpz`vLvuSuTLvuvsQ{kNvΘif>fMNO gsQ ُysQTSQNc~e0ُNSs[Q{_RpzvsQbwQ g͑'Yv4N^aIN0xvzbgShN_;Sf[v\g REuropean Heart Journal NIF=39.3 _w_uf[W TL^ltQ Tt^Bg_N(WEditorialhv[yxvzۏLċ ċNxvz(W_RpzWwQ g]'YaINTq_T0ُyxvz_NeQ 2021t^ Headline hitting research from the EHJ T 2021t^-NV_Rpz10'Yxvz 0vMR] g100Y[VEZSObSNbNvُyxvz SbVkeb0&Ofekeb0rzb0Drugs.com0MedscapeT~e-NV 0xvzbg_NNature MicrobiologyIF=28.3 I{ؚ4ls^Bg__(u [xvz(WMNO_puNvLvuSusv\o(W4N^NfMNO gsQ ُysQTSQNc~e0ُNSs[Q{_RpzvsQbwQ g͑'Yv4N^aIN0ُyxvzShN_;Sf[v\g REuropean Heart Journal N VvQ>fWv4N^aIN ُyxvzeQ N 2021 t^-NV_Rpz10 'Yxvz Te_N_w_uf[Wxvz TLvS_'YvtQ0'k2m_uf[Bg_[xvzNS^NNNe?z ċN9exvz(W_RpzWwQ gv]'YaINTq_T0vMR] g100 Y[VEZSObSNbNvُyxvz SbVkeb0&Ofekeb0rzb0Drugs.com0Medscape T~e-NV 0 ~ N ,gyv[_pWvxvzmS;Sf[Wvyx0ʋe0lu0(uo0^ Y0btI{Y*Neb yvv_U\ gRNcGSbV(W_pWvyxT;Su4ls^0 Te ,gyvL]TbV(W;SoLNv܏ĉR  YUO㉳QNSS&^egveP^ O_pNS|Q gHevlu 9eU_pNvu;m(ϑ0Vdk yv,g g͑vygaINT_'`0 7.c^^(u`Q e 8.wƋNCgfvU_ e Nh'`evU_ Ren QW, Yu SY, Teng TH, Li X, Cheung KS, Wu MZ, Li HL, Wong PF, Tse HF, Lam CSP, Yiu KH*. Statin use is associated with lower cancer risk and related mortality in patients with heart failure. Eur Heart J. 2021 Jun 22;ehab325.(JIF=35.855; Ranking=3/143; No. of cites=18; Google Scholar=25; corresponding author) * Yu SY, Ip SMM, Li X, Cheung KS, Ren QW, Wu MZ, Li HL, Wong PF, TSe HF,Yiu KH*. Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study. Plos Med. 2022 Jan 13; 19 (1):e1003880. (JIF=11.613; Ranking=20/172; No. of cites=1; Google Scholar=0; corresponding author)* Wu MZ, Chen Y, Yu YJ,Zhen Z, Liu YX, Zou Y, Lai MH, Lin QS, Ng MY, Lam KSL, Tse HF, Yiu KH*. Sex-specific pattern of left ventricular hypertrophy and diastolic function in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Imaging. 2020; 40(S1):2080.(JIF=9.13; Ranking=19/143, 10/136; No. of cites=2; Google Scholar= 4; corresponding author) * Tse YK, Li HL, Yu SY, Wu MZ, Ren QW, Huang J, Tse HF, Bax JJ, Yiu KH*. Prognostic value of right ventricular remodelling in patients undergoing concomitant aortic and mitral valve surgery. Eur Heart J Cardiovasc Imaging. 2022 Aug 22: (JIF=9.13;Ranking=19/143;4.10/136; No. of cites=0; Google Scholar=0) Wu MZ, Chen Y, Zou Y, Zhen Z, Yu YJ, Liu YX, Yuen M, Ho LM, Lam KSL, Tse HF, Yiu KH*. Impact of obesity on longitudinal changes to cardiac structure and function in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Imaging. 2019;20(7):816-27.(JIF=9.13; Ranking=19/143, 10/136; No. of cites=4; Google Scholar= 6;corresponding author) * Li HL, Lip GH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH*. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021 May 7;20(1):100. (JIF=8.949; Ranking=20/143, 15/146; No. of cites=41; Google Scholar=49; corresponding author) * Liu JH, Chen Y, Yuen M, Zhen Z, Chan CWs, Lam KSl, Tse HF, Yiu KH*. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2016;15:22.(JIF=8.949; Ranking=20/143, 15/146; No. of cites=63; Google Scholar= 97; corresponding author) * Wu MZ, Lee CH, Chen Y, Yu SY, Yu YJ, Ren QW, Fong HC, Wong PF, Tse HF, Lam SK, Yiu KH*. Association between adipocyte fatty acid-binding protein with left ventricular remodelling and diastolic function in type 2 diabetes: a prospective echocardiography study. Cardiovasc Diabetol. 2020 Nov 24;19(1):197.(JIF=8.949; Ranking=20/143, 15/146; No. of cites=4; Google Scholar=6; corresponding author) * Li HL, Tromp J, Teramoto K, Tse YK, Yu SY, Lam LY, Li KY, Wu MZ, Ren QW, Wong PF, Cheung CL, To KKW, Tse HF, Lam CSP, Yiu KH*. Temporal Trends and Patterns of Infective Endocarditis in a Chinese population: A Territory-Wide Study in Hong Kong (2002  2019). Lancet Regional Health-Western Pacific. 2022 Mar 4; 22: 100417. (JIF=8.559; Ranking=3/109; 20/210; 10/182, No. of cites=3; Google Scholar=1; corresponding author)* Wu MZ, Chandramouli C, Wong PF, Chan YH, Li HL, Yu SY, Tse YK, Ren QW, Yu SY, Tse HF, Lam CSP, Yiu KH*. Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors. Diabetes Metab. 2022 Nov;48(6):101367. (JIF=8.254; Ranking=19/146;10/136 No. of cites=1; Google Scholar=0) Yu YJ, Chen Y, Lau CP, Liu YX, Wu MZ, Chen YY, Ho ML, Tse HF, Yiu KH*. Non-apical right ventricular pacing is associated with less tricuspid valve interference and long-term progress of tricuspid regurgitation. J Am Soc Echocardiogr. 2020;33(11):1375-83.(JIF=7.722; Ranking=27/143; No. of cites=3, Google Scholar= N/A; corresponding author)* Chen Y, Liu YX, Yu YJ, Wu MZ, Lam YM, Sit KY, Chan DTL, Ho CKL, Ho LM, Fang LG, Zhang SY, Lau CP, Au WK, Tse HF, Yiu KH*. Prognostic value of tricuspid valve geometry and leaflet coaptation status in patients undergoing tricuspid annuloplasty: a three-dimensional echocardiography study. J Am Soc Echocardiogr. 2019;32(12):1516-25.(JIF=7.722; Ranking=27/143; No. of cites=3; Google Scholar=6; corresponding author) * Tse YK, Chandramouli C, Li HL, Yu SY, Wu MZ, Ren QW, Chen Y, Wong PF, Sit KY, Chan TLD, Ho KLC, Au WK, Li XL, Tse HF, Lam SPC, Yiu KH*. Concomitant hepatorenal dysfunction and malnurition in valvular heart surgery: Long-term Prognostic Implications for Death and heart Failure. Journal of American Heart Association. 2022; 11: e024060. (JIF=6.107; Ranking=42/143; No. of cites=0; Google Scholar=0; corresponding author)* Chan YH, Ngai MC, Chen Y, Wu MZ, Yu YJ, Zhen Z, Lai K, Cheung T, Ho LM, Chung HY, Lau CS, Tse HF,Yiu KH*. Cumulative Rheumatic Inflammation Modulates the Bone-Vascular Axis and Risk of Coronary Calcification. J Am Heart Assoc. 2019;8(11):e011540.(JIF=6.106; Ranking=42/143; No. of cites=4; Google Scholar= 5; corresponding author)* Chen Y, Liu YX, Seto WK, Wu MZ, Yu YJ, Lam YM, Au WK, Chan D, Sit KY, Ho LM, Tse HF, Yiu KH*. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.J Am Heart Assoc. 2018;7(14):e009020(JIF=6.106; Ranking=42/143; No. of cites=29; Google Scholar= 37; corresponding author)* Chen Y, Liu JH, Chan D, Sit KY, Wong CK, Ho KL, Ho LM, Zhen Z, Lam YM, Lau CP, Au WK, Tse HF, Yiu KH*. Prevalence, Predictors and Clinical Outcome of Residual Pulmonary Hypertension Following Tricuspid Annuloplasty. J Am Heart Assoc. 2016;5(7):e003353.(JIF=6.106; Ranking=42/143; No. of cites=11; Google Scholar= 17; corresponding author) Chen C, Liu S, Cao G, Hu Y, Wang R, Wu M, Liu M, Yiu KH*. Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin via Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis. Front Cardiovasc Med. 2022 Jul 5;9:695004 (JIF=5.848; Ranking=43/143; No. of cites=1; Google Scholar=0) Chen C, Cai S, Wu M, Wang R, Liu M, Cao G, Dong M, Yiu KH*. Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation. Dis Markers. 2022 May 2;2022:2948578 (JIF=3.464; Ranking= 76/159; 87/175; 86/139; 33/77 No. of cites=0; Google Scholar=0) Cao GZ, Chen C, Lin QS, Chen Y, Zhen Z, Zou Y, Liu JH, Wu M, Wang R, Liu MY, Zhao CT, Lu SK, Ng MY, Tse HF, Yiu KH*. Prevalence, clinical characteristics and echocardiography parameters of non-resistant, resistant and refractory hypertension in Chinese. Postgrad Med. 2017;129(2):187-92.(JIF=4.379; Ranking=58/172; No. of cites=10; Google Scholar= 12; corresponding author) 10.[bN`Q SbY T0c T0Ly0L?eLR0]\OUSMO0[bUSMO [,gyvv!.s Y/TR`(,{N[bN) Ly/LRYec Rtb0_@{~TQy;N{ ]\OUSMO/n'Yf[m3W;Sb [bUSMO/n'Yf[m3W;Sb0/n'Yf[ [,gyvv!.s\O:Nyv;N#N #teSOyvvTgbL Oyvؚ(ϑv[b00RvMR:Nbk ]ShǏ200{xvzWe vQ-NN,{N\Ob\ONShve;`70YO{ Nh\O6eU_N_v\g REuropean Heart JournalIF=39.3 0SNVEVQf[/gOv^[f[/gbgۏLNbJTY!k (WPCR Tokyo Valves 2019f[/gO NcgsOXdVY,{N T0N(W4N^W Y/TR`Yec/fN2mgeccT[e~[{;NR tnbc/gTAVI v;SuKNN(WYYecv&^ N _QyN2020t^_m3W^kSueP^YXTO͑pSU\NNVY-͑pWf[y0SY Y/TR`Yec,gN/f,{23J\o'Y)RN;SuOePhQ(ϑ9eۏhQtVYv_ N&^vy[_N/fVYy N(WN2m/UNSv:gg0YYec:NQ0WN-NV/n0V0eRaW_@{WybSU\NbgNAm-d^s^S cGSNbV_@{W_pWvybbg(WNLu Nvq_TR0 yv#NTV!kbS O(uN@l{|oirN_Rpz`vLvuSuTLvuvsQ{kNvΘif>fMNO gsQ ُysQTSQNoirvc~e0Ss[Q{_RpzvsQbwQ g͑'YaIN0NN\xvzbgShN_;Sf[v\g REuropean Heart Journal NIF=39.3 _w_uf[ TLv^ltQ Tt^Bg_N(WEditorialhv[yxvzۏLċ ċNxvz(W_RpzWwQ g͑aINTq_T0ُyxvz_NeQ  2021t^-NV_Rpz10'Yxvz 0 H.t(,{N[bN) Ly/LRoR;NN;S^ oR~;Su ]\OUSMO/n'Yf[m3W;Sb0 [bUSMO/n'Yf[m3W;Sb [,gyvv!.s\O:Nyvv;NSNN #yvvdQ0gbLTbgtet Oyv cR[e0\O:N_@{W g~vN[ #yv'Y~vdQ 6R[q_Pf[0W~pencU_eQhQ nx[U_eQvpencB*ph CJOJPJQJ^Jo(aJ5@mH sH nHtH\8B*phCJOJPJQJ^Jo(aJmH sH nHtH_H*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\8B*phCJOJPJQJ^Jo(aJmH sH nHtH_H$B*phCJOJPJQJo(aJ@*B*ph CJOJPJQJo(aJ5@\ 4 6 t x ƫ}jYC-*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\!B*phCJOJPJQJaJ@$B*phCJOJPJQJo(aJ@4B*phCJOJPJQJo(aJ@mH sH nHtH$B*phCJOJPJQJo(aJ@4B*phCJOJPJQJo(aJ@mH sH nHtH$B*phCJOJPJQJo(aJ@$B*phCJOJPJQJo(aJ@$B*phCJOJPJQJo(aJ@ гp[F-0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH0B*phCJOJPJQJ^Jo(aJ@nHtH*B*ph CJOJPJQJo(aJ5@\ jlnɴuXC.(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH RTVbd.02͸wbM40B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@*B*phCJOJPJQJo(aJ5@\*B*phCJOJPJQJo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH 2462468:ɴiP;&(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH   B!D!F!V!X!ɰq\G1*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH0B*phCJOJPJQJ^Jo(aJ@nHtH X!Z!\!p!r!t!v!!!!!տiS=*%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@ !!("4"6"8":"##8$D$xeR?)+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\ D$H$R$$$$$&&&&ë{hS@*+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@ &D'F'T'V'X'B(b)d)f))ϷkXC0%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq 8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@ ))))))))):++lO<'(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\ +++^,l,p,Z-x.z.|..ë|iTA.%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@ .... ///0111fS>+%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\ 1J1X1111j2l3n3p3z3ë|iTA++B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@ z3334446667 7ízeR<)%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@>B*phCJOJPJQJ^Jo(aJ5@mH sH nHtH\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@ 77v77778999T:yfS=*%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\ T:`::::4<6<t<~<<<oYF0+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\ <<<>>>?????ѾmZB/%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\.B*phCJOJPJQJ^Jo(aJ5@\ ?A"B$BpBzB~BB"C0ClEнkX@-%B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq lEnEEE0F>FBF GHHHðiVA.%B*phCJOJPJQJ^JaJ@(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@ H:HDHHHHIIIJJë|iL9$(B*phCJOJPJQJ^Jo(aJ@%B*phCJOJPJQJ^JaJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@ JJKKKKLMMMMë|iV@-%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@6B*phCJOJPJQJ^JaJ@fHq %B*phCJOJPJQJ^JaJ@.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@ MMMMPPPPPhPtPѻlVC-+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\ tPvPxP2R4R@RBRPR SSSѾlYC+.B*phCJOJPJQJ^Jo(aJ5@\+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@+B*phCJOJPJQJ^JaJ5@\.B*phCJOJPJQJ^Jo(aJ5@\ SU U"U$UxUzUUUUUƵtWB%8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH.B*phCJOJPJQJ^Jo(aJ5@\$B*ph CJOJPJQJo(aJ@*B*ph CJOJPJQJo(aJ5@\!B*ph,CJOJPJQJaJ@$B*ph,CJOJPJQJo(aJ@%B*phCJOJPJQJ^JaJ@%B*phCJOJPJQJ^JaJ@ UUUUUUUVVį|^@":B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@:B*phCJOJPJQJo(aJ5@mH sH nHtH\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtHVVXX8Y:Y[ [[[Ͱq\D'8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH.B*phCJOJPJQJ^Jo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH [[[[*[@[B[L[^[`[Ͱ}hJ5 (B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@:B*phCJOJPJQJo(aJ5@mH sH nHtH\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@:B*phCJOJPJQJo(aJ5@mH sH nHtH\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@ `[h[j[z[|[[\\\\Ѽu`H+8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH.B*phCJOJPJQJ^Jo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@ \\\\\\]]ͰnP2:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\AB*phCJOJPJQJ^Jo(aJ7S*@ *mH sH nHtHAB*phCJOJPJQJ^Jo(aJ7S*@ *mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@]*],]<],^.^4^6^@^æ|dG2(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH.B*phCJOJPJQJ^Jo(aJ5@\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\@^B^D^T^^^`^z^|^^ŧ}_A#:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@:B*phCJOJPJQJo(aJ5@mH sH nHtH\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH^^^_______į~aL3(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH6B*phCJOJPJQJ^Jo(aJ5@nHtH\(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH:B*phCJOJPJQJo(aJ5@mH sH nHtH\ _____2`4`X`Z`ŦmN/.B*phCJOJPJQJ^Jo(aJ5@\=B*phCJOJPJQJo(aJ5@ *mH sH nHtH\=B*phCJOJPJQJo(aJ5@ *mH sH nHtH\=B*phCJOJPJQJo(aJ5@ *mH sH nHtH\3B*phCJOJPJQJ^Jo(aJ@ *mH sH =B*phCJOJPJQJo(aJ5@ *mH sH nHtH\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtHZ`j```aaa aaʹ{fI4(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH6B*phCJOJPJQJ^Jo(aJ5@nHtH\0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtHaaa4a6aPaRalaŦnP2:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\:B*phCJOJPJQJo(aJ5@mH sH nHtH\3B*phCJOJPJQJ^Jo(aJ@ *nHtH=B*phCJOJPJQJo(aJ5@ *mH sH nHtH\8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtHlana~aaaaabbīqXB,*B*ph CJOJPJQJo(aJ5@\*B*ph CJOJPJQJo(aJ5@\0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH:B*phCJOJPJQJo(aJ5@mH sH nHtH\bbb.b0b>b@bVcXcZcɴq\G2(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH Zcfcpcrcccdd͸u`(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@0B*phCJOJPJQJ^Jo(aJ@nHtH(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@(B*phCJOJPJQJ^Jo(aJ@8B*phCJOJPJQJ^Jo(aJ@mH sH nHtH  .8zG2 & F 8d G$ 88$7$1$$$$9D4$5$6$3$H$A$C$VD^WD` & Fd G$8$7$1$$$$9D4$5$6$3$H$A$C$& & F 8d G$ 88$7$1$$$$9D4$5$6$3$H$A$C$ G$H$WD:`:a$$A$G$8$7$1$$$$9D4$5$6$3$H$a$$A$G$8$7$1$$$$9D4$5$6$3$H$8\fx6 Y6#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$2 & F 8d G$ 88$7$1$$$$9D4$5$6$3$H$A$C$VD^WD`! & Fd G$8$7$1$$$$9D4$5$6$3$H$A$C$VD2 & F 8d G$ 88$7$1$$$$9D4$5$6$3$H$A$C$VD^WD` & Fd G$8$7$1$$$$9D4$5$6$3$H$A$C$6 lfC#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$G$H$ G$H$WD:`: d G$8$7$1$$$$9D4$5$6$3$H$A$WD$`$lTVd04nK#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$G$H$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$4 D!F!X!\!r!snKFG$H$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$G$H$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$r!v!!#&f)+|.gN & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & F 8G$ 8H$C$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$|.1p3696<>$BiP & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z$BnEHJMP4R U"UiPKG$H$ & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z & Fa$$G$H$C$VD^WDz`z"U$UzUUUUV:Y}`d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$G$H$G$H$:Y [[B[`[|[\dGd a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$#d a$$A$G$8$7$1$$$$9D4$5$6$3$H$WD$`$\\\],].^D^jI!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$D^`^|^^___jMd a$$A$G$8$7$1$$$$9D4$5$6$3$H$!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$\\664j4j 8.^W`Wo(.  8.\4j6&666666666vvvvvvvvv664<<6>6666466666666666666666666666666666666666666666666hH666646666666666<466666666666666666666666666666666666666666666664p666 0@P`p6(66 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`pN@Ncke a$$1$$CJOJQJKHmH sH nHtH_H$A@$؞k=W[SONi@N0nfh?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[86 l4r!|.$B"U:Y\D^_RaZcd\]^_`abcdefghijL.7$.{$  Calibri-([SOG.[x @Times New Roman;4 N[_GB23121$ P<*_oŖў-4 |8N[G.[x @Times New Romanlenovo\H QhjG ƇCk) \!f!),.:;?]}    & 6"0000 0 0 00000 =@\]^([{  0 0 00000;[P)$P32d(d(d(d(_4`Z``a6aRajMd a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$!d XD2a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$Ranaaab0bXcZc{^d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$G$H$ G$H$WD8`8d a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$Zcrcdd a$$A$G$8$7$1$$$$9D4$5$6$3$H$d a$$A$G$8$7$1$$$$9D4$5$6$3$H$1. A!#"$%S2P18bpu R QS^>w,(N) *J)+ 1MR1-b2~#6X6F7aq7\B8Q?LGC(uCMHVHiJEL,QlSTy(V9ZM[aAa7caecKe~fdgvgh-jHnt0ykz"u}p&*uBtPMZ#+4Ix3L*5Ml]qf8Q_9<siX=#U.Ef(g l ZV6=uC(5eij=6,Hm@c#" g hxo+/K\cF#'%6'%'(71*n1R1'3=jT42wc4/Ed4{56{6#-7Nd8Mr9:n